Together with the discovery of DNMT1 mediated epigenetic regulation on ND6 expression and associated metabolic changes, these findings may shed light on potential therapeutic strategies from a perspective of mitochondrial epigenetics for the prevention and treatment of insulin resistance and related metabolic disorders. The gene discussed is MT-ND6; the disease is Insulin resistance.